Asset Details
Do you wish to reserve the book?
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks
Do you wish to request the book?
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks
2024
Overview
The development of flares or new-onset of immune-mediated dermatologic diseases, including psoriasis, has occurred with the worldwide spreading of the COVID-19 pandemic. We report the case of a 38-year-old woman who came to our department with a severe flare of plaque psoriasis four weeks after SARS-CoV-2 infection. Her Psoriasis Area Severity Index was 25, and her Dermatology Life Quality Index was 18. Our initial decision was to prescribe acitretin, but the patients reported adverse events. For this reason, we started risankizumab with complete skin clearance after 16 weeks. The patient is still on treatment, and no adverse events have been reported to date.
Publisher
PAGEPress Publications,PAGEPress Publications, Pavia, Italy
Subject
